EUVIMEDEUVIMED entdecken
Open Access

IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis

Shelby E Compton iD, Lisa M DeCamp, Brandon M Oswald iD, Susan M Kitchen-Goosen iD, Kin H Lau iD, Robert Fillinger, Michael S Dahabieh iD, Alexandra Vander Ark iD, Connie M Krawczyk iD, Russell G Jones iD

Science Advances · 2025

DOI: 10.1126/sciadv.adt5933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Shelby E Compton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA. Hauptthemen laut MEDLINE: Interleukin-17, Protein Serine-Threonine Kinases, Inflammation, Peutz-Jeghers Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the tumor suppressor liver kinase B1 (LKB1) promote the development of gastrointestinal (GI) polyps of unknown etiology. Here, we identify IL-17 as a novel driver of LKB1-dependent polyp growth. GI tumors from mice bearing heterozygous mutations in Stk11 (which encodes LKB1) display signatures of pathogenic IL-17–producing CD4 + T helper 17 (T H 17) cells. LKB1 constrains T cell inflammatory potential, as Stk11 /LKB1 haploinsufficiency promotes T cell differentiation toward pathogenic IL-17–producing T cell lineages (CD4 + T H 17 and CD8 + T c 17) in vitro and following intestinal infection. Mechanistically, aberrant CREB-regulated transcription coactivator 2 (CRTC2)–dependent signaling drives pathogenic T H 17 cell programs downstream of LKB1 haploinsufficiency. Targeting this circuit via CRTC2 deletion or IL-17 blockade antagonizes GI polyp growth in mouse models of Peutz-Jeghers syndrome. These findings establish LKB1 as a gatekeeper of inflammatory type 3 (IL-17–dependent) T cell responses and identify a CRTC2–IL-17 signaling axis that can be targeted therapeutically to block the growth of LKB1 mutant GI tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17Protein Serine-Threonine KinasesInflammationPeutz-Jeghers SyndromeAnimalsMiceAMP-Activated Protein Kinase KinasesTh17 CellsHumansSignal TransductionDisease Models, AnimalMutationAMP-Activated Protein Kinases

Substanzen

Interleukin-17Protein Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesStk11 protein, mouseAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, USA.
  • Bioinformatics and Biostatistics Core, Van Andel Institute, Grand Rapids, MI, USA.
  • Metabolism and Nutrition (MeNu) Program, Van Andel Institute, Grand Rapids, MI, USA.

ORCID-Profile: Shelby E Compton, Brandon M Oswald, Susan M Kitchen-Goosen, Kin H Lau, Michael S Dahabieh, Alexandra Vander Ark, Connie M Krawczyk, Russell G Jones

Förderung

  • NIAID NIH HHS

Zitieren

APA

Compton, S. E., DeCamp, L. M., Oswald, B. M., Kitchen-Goosen, S. M., Lau, K. H., Fillinger, R., Dahabieh, M. S., Ark, A. V., Krawczyk, C. M., & Jones, R. G. (2025). IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis. Science Advances. https://doi.org/10.1126/sciadv.adt5933

Vancouver

Compton SE, DeCamp LM, Oswald BM, Kitchen-Goosen SM, Lau KH, Fillinger R, et al. IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis. Science Advances. 2025. doi:10.1126/sciadv.adt5933

BibTeX
@article{Compton2025,
  author = {Compton, Shelby E and DeCamp, Lisa M and Oswald, Brandon M and Kitchen-Goosen, Susan M and Lau, Kin H and Fillinger, Robert and Dahabieh, Michael S and Ark, Alexandra Vander and Krawczyk, Connie M and Jones, Russell G},
  title = {IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt5933}
}
Kostenlos starten →